The relationship between ghrelin levels and insulin resistance in men with idiopathic hypogonadotrophic hypogonadism at diagnosis and after therapy

Endokrynologia Polska

Volumn 61, Issue 4, 2010, Pages 351-358

  Naharci, M Ilkin ^a   Bolu, Erol ^a   Karadurmus, Nuri ^a   Basaran, Yalcin ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Ghrelin; Insulin resistance; Testosterone replacement therapy

Indexed keywords

GHRELIN; GLUCOSE; INSULIN; NANDROLONE DECANOATE; TESTOSTERONE; TESTOSTERONE PHENYLPROPIONATE; TESTOSTERONE PROPIONATE;

ADULT; ANDROGEN THERAPY; ARTICLE; BODY FAT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INSULIN RESISTANCE; MALE; PATIENT COMPLIANCE; REPRODUCTION; SCORING SYSTEM;

ADULT; GHRELIN; HUMANS; HYPOGONADISM; INSULIN RESISTANCE; MALE; TESTOSTERONE; YOUNG ADULT;

EID: 77957267851     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Hunter SJ, Garvey WT. Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system. Am J Med 1998; 105: 331-335.
2. Gnacińska M, Małgorzewicz S, Lysiak-Szydłowska W et al. The serum profile of adipokines in overweight patients with metabolic syndrome. Endokrynol Pol 2010; 61: 36-41.
3. Lichtenstein MJ, Yarnell JWG, Elwood PC et al. Sex hormones, insulin, lipids, and prevalent ischemic heart. Am J Epidemol 1987; 126: 647-657.
4. Pasquali R, Casimirri F, Cantobelli S et al. Effects of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 1991; 40: 101-104.
5. Phillips GB. Relationship between sex hormones and glucose, insulin, and lipid abnormalities in men with myocardial infarction. Proc Nat Acad Sci 1977; 74: 1729-1733.
6. Seidell JC, Bjorntop P, Sjostrom LS et al. Visceral fat accumulation in men is positively associated with insulin, glucose, and c-peptide levels, but negatively with testosterone levels. Metabolism 1990; 39: 897-901.
7. Simon D, Preziosi P, Barrett-Connor E et al. Interrelationship between plasma testosterone and plasma insulin in healthy adult men: the telecom study. Diabetologia. 1992; 35: 173-177.
8. Cohen JC, Hickman R. Insulin resistance and diminished glucose tolerance in power lifters ingesting anabolic steroids. J Clin Endocrinol Metab 1987; 64: 960-963. (Pubitemid 17067428)
9. Holmang A, Bjorntorp P. The effects of testosterone on insulin sensitivity in male rats. Acta Physiol Scand 1992; 146: 505-10.
10. Shoupe D, Lobo RA. The influence of androgens on insulin resistance. Fertil Steril. 1984; 41: 385-388.
11. Marsden PJ, Murdock AP, Taylor R. Adipocyte insulin action in hypogonadotropic hypogonadism. Hum Reprod. 2000; 15: 1672-1678.
12. Pagotto U, Gambineri A, Vicennati V et al. Plasma ghrelin, obesity, and the polycystic ovary syndrome. Correlation with insulin resistance and androgen levels. J Clin Endocrinol Metab. 2002; 87: 5625-5629. (Pubitemid 36034369)
13. Kojima M, Hosoda H, Date Y. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999; 402: 656-660.
14. Ariyasu H, Takaya K, Tagami T et al. Stomach is a major source of circulating ghrelin and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab. 2001; 86: 4753-4758.
15. Pöykkö SM, Kellokoski E, Hörkkö S et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003; 52: 2546-2553.
16. Barkan AL, Dimaraki EV, Jessup SK et al. Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by ambient growth hormone levels. J Clin Endocrinol Metab. 2003; 88: 2180-2184.
17. Skoczylas A, Adamczak M, Chudek J et al. Cilazapril increases plasma ghrelin concentration in obese patients with arterial hypertension. Endokrynol Pol 2010; 61: 21-27.
18. Nagaya N, Kojima M, Uematsu M et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 2001; 280: 1483-1487.
19. Tschöp M, Weyer C, Tatarannni PA et al. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001; 50: 707-709. (Pubitemid 32242624)
20. Pagotto U, Gambineri A, Pelusi C et al. Testosterone replacement therapy restores normal ghrelin in hypogonadal men. J Clin Endocrinol Metab. 2003; 88: 4139-43. (Pubitemid 37153711)
21. Siemińska L, Wojciechowska C, Kos-Kudła B et al. Serum concentrations of leptin, adiponectin and interleukin-6 in postmenopausal women with Hashimoto's thyroiditis. Endokrynol Pol 2010; 61: 112-116.
22. Reilly JJ, Wilson J, Mccoll JH et al. Ability of bioelectric impedance to predict fat-free mass in prepubertal children. Pediatr Res 1996; 39: 176-179.
23. Naharci MI, Pinar M, Bolu E et al. Effect of testosterone on insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism. Endocr Pract 2007; 13: 629-35.
24. Bhasin S, Woodhouse L, Storer TW. Proof of the effect of testosterone on skeletal muscle. J Endocrinol 2001; 170: 27-38. (Pubitemid 32677563)
25. Boyanov MA, Boneva Z, Christov VG. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male 2003; 6: 1-7.
26. Corrales JJ, Burgo RM, Garca-Berrocal B et al. Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control. Metabolism. 2004; 53: 666-672.
27. Marin P, Holmang S, Jonsson L. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 1992; 16: 991-997.
28. Singh AB, Hsia S, Alaupovic P. The effects of varying doses of testosterone on insulin sensitivity, plasma lipids, apolipoproteins, and c-reactive protein in healthy young men. J Clin Endocrinol Metab 2002; 87: 136-143.
29. Tripathy D, Shah P, Lakshmy R et al. Effect of testosterone replacement on whole body glucose utilization and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism. Horm Metab Res. 1998; 30: 642-645. (Pubitemid 28523429)
30. Dunaif A. Insulin resistance and the polycytic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997; 18: 774-800.
31. Ikezaki A, Hosoda H, Ito K et al. Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents. Diabetes 2002; 51: 3408-3411.
32. Shiiya T, Nakazato M, Mizuta M et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab. 2002; 87: 240-244.
33. Bjorntop P. The regulation of adipose tissue distribution in humans. Int J Obes 1996; 20: 291-302. (Pubitemid 26110403)
34. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the Metabolic Syndrome. Endocr Rev 2000; 21: 697-738.
35. Broglio F, Benso A, Gottero C et al. Effects of glucose, fatty acids or arginine load on the Gh-releasing activity of ghrelin in humans. Clin Endocrinol 2002; 57: 265-271.
36. Mohlig M, Spranger J, Otto B et al. Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. J Endocrinol Invest 2002; 25: 36-38.